EU ingredient rules · 1 min read

Hydrogenated Tallowamide DEA in cosmetics: EU rules

Quick answer: Hydrogenated Tallowamide DEA is a restricted cosmetic ingredient in the EU: Annex III (entry 60) allows it only within set limits. CosIng lists its functions as foam booster, light stabilizer, cleansing surfactant and viscosity controlling.

Key facts

Hydrogenated Tallowamide DEA at a glance
INCI nameHYDROGENATED TALLOWAMIDE DEA
CAS number68440-32-4
EC number270-450-2
EU statusRestricted (Annex III, entry 60)
Functions (CosIng)Foam booster, Light stabilizer, Cleansing surfactant, Viscosity controlling

CosIng description: Fatty acids, tallow, reaction products with diethanolamine

What it does in a product

  • Foam booster: Makes the lather richer or longer lasting.
  • Light stabilizer: Protects the formula itself from being broken down by light.
  • Cleansing surfactant: Washes away dirt and oil.
  • Viscosity controlling: Thickens or thins a product.

Annex III: restricted substances, entry 60

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Fatty acid dialkylamides and dialkanolamides

Maximum concentration in the ready-to-use product:

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for HYDROGENATED TALLOWAMIDE DEA and Annex III/60, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.